1. Home
  2. JAZZ vs H Comparison

JAZZ vs H Comparison

Compare JAZZ & H Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$254.86

Market Cap

15.6B

Sector

Health Care

ML Signal

HOLD

Logo Hyatt Hotels Corporation

H

Hyatt Hotels Corporation

HOLD

Current Price

$189.65

Market Cap

17.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
H
Founded
2003
1957
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
15.6B
17.8B
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
JAZZ
H
Price
$254.86
$189.65
Analyst Decision
Strong Buy
Buy
Analyst Count
14
15
Target Price
$217.57
$179.53
AVG Volume (30 Days)
789.8K
696.7K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
0.38%
EPS Growth
N/A
N/A
EPS
4.43
0.40
Revenue
$1,618,693,000.00
$4,685,000,000.00
Revenue This Year
$6.22
$110.63
Revenue Next Year
$7.68
$7.01
P/E Ratio
$54.96
$473.69
Revenue Growth
N/A
5.78
52 Week Low
$105.00
$133.51
52 Week High
$250.49
$206.86

Technical Indicators

Market Signals
Indicator
JAZZ
H
Relative Strength Index (RSI) 65.44 49.67
Support Level $222.49 $182.02
Resistance Level N/A $206.86
Average True Range (ATR) 7.53 4.96
MACD 0.49 -0.81
Stochastic Oscillator 99.98 60.21

Price Performance

Historical Comparison
JAZZ
H

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About H Hyatt Hotels Corporation

Hyatt is an operator of owned (2% of total rooms) and managed and franchised (98%) properties across about 35 upscale luxury brands, which include vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. Regional exposure, as a percentage of total rooms, is 45% for the US, 31% for the rest of the world, and 24% for Asia-Pacific.

Share on Social Networks: